Gardasil HPV
Selected indexed studies
- Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials. (Hum Vaccin Immunother, 2023) [PMID:36916016]
- Opportunities and challenges for human papillomavirus vaccination in China. (Hum Vaccin Immunother, 2024) [PMID:38575524]
- HPV vaccination with Gardasil: a breakthrough in women's health. (Expert Opin Biol Ther, 2006) [PMID:17049018]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. (2015) pubmed
- Adverse events following 9-valent human papillomavirus vaccine (GARDASIL® 9) reported to the Vaccine Adverse Event Reporting System (VAERS), 2015-2024. (2025) pubmed
- Opportunities and challenges for human papillomavirus vaccination in China. (2024) pubmed
- Gardasil-9: A global survey of projected efficacy. (2016) pubmed
- Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials. (2023) pubmed
- HPV vaccination with Gardasil: a breakthrough in women's health. (2006) pubmed
- [HPV vaccination]. (2016) pubmed
- Impact of HPV vaccination with Gardasil® in Switzerland. (2017) pubmed
- Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study. (2021) pubmed
- Human papillomavirus vaccines. (2006) pubmed